In conclusion, our findings demonstrated that miR-640 is downregulated in BC tissues and cell lines, and is able to suppress BC tumorigenesis in vitro and in vivo through directly targeting Wnt7b and Wnt/β-catenin signaling pathway. This evidence concerns the gene WNT7B and breast cancer.